Ctmx shares
WebApr 14, 2024 · A number of hedge funds and other institutional investors have recently added to or reduced their stakes in CTMX. UBS Group AG grew its stake in CytomX … WebCytomX Therapeutics Inc (CTMX) Stock Price Today, News, Quotes, FAQs and Fundamentals 3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here. CTMX CytomX Therapeutics Inc 2,597 $1.54 $0.03 (1.99%) Today Market Cap $100M Volume (M) 506,367.00 52-Wk High $3.02 52-Wk Low $1.17 About Feed Sentiment …
Ctmx shares
Did you know?
WebApr 13, 2024 · CytomX Therapeutics Inc. CTMX, +7.19% shares soared more than 50% in the extended session Thursday after the small biotech company announced a … WebDec 27, 2024 · Accordingly, the analyst maintained a Buy rating and a $15 price target for CTMX shares, suggesting upside of a hefty 279% from current levels. (To watch Pohlman’s track record, click here ...
WebApr 7, 2024 · See the latest CytomX Therapeutics Inc stock price (NASDAQ:CTMX), related news, valuation, dividends and more to help you make your investing decisions. WebShares Sold Short 1.27 M Change from Last -7.69% Percent of Float 1.97% Stock Money Flow N/A PROFILE ( CTMX) CytomX Therapeutics, Inc. engages in the development of …
Web2 days ago · CytomX Therapeutics - CTMX - Stock Price Today - Zacks CytomX Therapeutics (CTMX) (Delayed Data from NSDQ) $1.86 USD -0.10 (-5.10%) Updated … WebJan 14, 2024 · CytomX Therapeutics Inc (CTMX) shares closed today at 1.6% above its 52 week low of $3.68, giving the company a market cap of $245M. The stock is currently down 13.2% year-to-date, down 50.8% over ...
WebApr 14, 2024 · CytomX Therapeutics, Inc. (NASDAQ:CTMX - Get Rating) has received an average rating of "Hold" from the twelve analysts that are covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, nine have given a hold recommendation and two have as Skip to main content S&P 500 …
WebMar 30, 2024 · CTMX stock opened at $1.54 on Thursday. The company has a market capitalization of $101.43 million, a PE ratio of -1.03 and a beta of 0.69. CytomX Therapeutics, Inc. has a 12 month low of $1.17... greedy oil companyWebCytomX Therapeutics, Inc. engages in the development of antibody therapeutics for the treatment of cancer based on its Probody therapeutic technology platform. Its pipeline … greedy notes from a bisexualWebCytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody … flounder tomatoes olivesWebCTMX: Get the latest CytomX stock price and detailed information including CTMX news, historical charts and realtime prices. ... On Monday 03/27/2024 the closing price of the … greedy ones clueWebApr 14, 2024 · The consensus estimate for Berry’s current full-year earnings is $0.81 per share. Capital One Financial also issued estimates for Berry’s Q3 2024 earnings at $0.21 EPS, Q4 2024 earnings at $0. ... flounder teasersWebIn last trading session, CytomX Therapeutics Inc. (NASDAQ:CTMX) saw 1.36 million shares changing hands with its beta currently measuring 0.45. Company’s recent per share … flounder tempuraWebApr 10, 2024 · NASDAQ:CTMX CytomX Therapeutics - CTMX Stock Forecast, Price & News $1.60 +0.04 (+2.56%) (As of 04/10/2024 12:00 AM ET) Compare Today's Range … greedy one crossword